ArticleDementia & neuropsychologia

Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study.

Luis Felipe José Ravic de Miranda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.